Risk of CNS adverse events (CNS-AEs) for patients with non-small cell lung cancer (NSCLC) and melanoma brain metastases (BM) treated with CNS radiation (CNS-RT) and immune checkpoint inhibitors (CPIs).
Year: 2018
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Michael Edward Devitt, Ralph Sumner Abraham, Jacobi Hines, Bethany J Horton, Camilo E. Fadul, James Mitchell Larner, Jason Sheehan, Richard Delmar Hall, Ryan D. Gentzler
Institutions: University of Virginia, University of Virginia Medical Center
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2890464628
